Radical new approach: cutting out tumors after drugs for tough liver cancers
NCT ID NCT04649489
Summary
This study is for adults with a specific, hard-to-treat form of liver cancer that has spread into major blood vessels. It tests if adding surgery to remove the tumor after initial drug therapy works better than continuing drugs alone. The goal is to see if this aggressive combination can better control the cancer and help patients live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS THROMBOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anhui Provincial Hospital
Hefei, China
-
Beijing Cancer Hospital
Beijing, China
-
Cancer Hospital Chinese Academy of Medical Science
Beijing, China
-
Fujian Provincial Hospital
Fuzhou, China
-
Guangxi Medical University Cancer Hospital
Nanning, China
-
Henan Province People Hospital
Zhengzhou, China
-
Jiangsu Provine People Hospital
Nanjing, China
-
Mengchao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, China
-
Peking Union Medical College Hospital
Beijing, China
-
Peking Univerty People's Hospital
Beijing, China
-
Shanghai Jiao Tong University Ruijin Hospital
Shanghai, China
-
Sun Yat-sen University Cancer Center
Guangzhou, China
-
The First Affiliated Hospital Of Guangxi Medical University
Nanning, China
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
-
The First Hospital of Lanzhou University
Lanzhou, China
-
The Second Affiliated Hospital Kunming Medical University
Kunming, China
-
The Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China
-
Tongji Hospital of Tongji Medical College of HUST
Wuhan, China
-
West China Hospital of Sichuan University
Chengdu, China
-
Xiangya Hospital of Central South University
Changsha, China
-
Zhongshan hospital, Fudan University
Shanghai, Shanghai Municipality, 200000, China
Conditions
Explore the condition pages connected to this study.